Science, technology and the emergence of AI have converged to make precision medicine for acute care a reality. This is how we deliver healthcare tailored to biology.
Research & Development
Evidence
Clinical Trials
The Sepsis ImmunoScore® Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available Biomarkers
Read More →
Prenosis is developing a pipeline of integrated diagnostics and therapeutics grounded in each patient's unique biological profile, using deep data science and AI to give clinicians tools that reflect the true complexity of critical disease.
Immunix®
Sepsis ImmunoScore®
BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease
Read More →
Blogs, articles, videos, and podcasts exploring how precision medicine and AI are changing the way clinicians detect and treat critical conditions.
Resource Library
Events
Treating the Patient, Not the Disease
Read More →
Read the latest Prenosis peer-reviewed articles and items from scholarly journals.
Newsroom
Sepsis ImmunoScore Outperforms Conventional Sepsis Tools
Read More →
As a biology-based technology company, we combine data science with AI to transform how critical conditions are diagnosed and treated.
Mission, Vision & Values
Careers
Leadership
Awards
LifeBridge Health deploys Prenosis’ FDA-authorized AI tool to speed sepsis detection
Read More →
5th World Sepsis Congress | Session 10 | AI Solutions for Sepsis
Session originally published by World Sepsis Congress May 20, 2025
Nathan Shapiro, MD, MPH, Professor of Emergency Medicine at Harvard Medical School and attending physician at Beth Israel Deaconess Medical Center, joins panelists Sujoy Kar and Ian Hosein to discuss AI solutions for sepsis.